Positive results from midstage trial of Pfizer’s cancer cachexia drug

Pfizer announced positive results from a midstage trial of its experimental drug for cancer cachexia, a condition that causes cancer patients to lose weight and appetite. The drug, ponsegromab, showed

Detail